Synthetic studies towards diazepanone scaffolds

Tetrahedron Asymmetry

Volumn 20, Issue 20, 2009, Pages 2320-2330

  Monasson, Olivier ^a   Ginisty, Maryon ^a   Mravljak, Janez ^a   Bertho, Gildas ^a   Gravier Pelletier, Christine ^a   Le Merrer, Yves ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; AZIDE; EPOXIDE; ISOASCORBIC ACID; KETONE DERIVATIVE; SERINE DERIVATIVE;

ALKYLATION; AMINATION; ARTICLE; ENANTIOMER; ENANTIOSELECTIVITY; EPOXIDATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; SYNTHESIS;

EID: 71849089654     PISSN: 09574166     EISSN: 1362511X     Source Type: Journal    
DOI: 10.1016/j.tetasy.2009.09.022     Document Type: Article

References (75)

1. For example, see:. Walsh C., and Wright G. Chem. Rev. 105 (2005) 391 and all references of this volume dedicated to antibiotic resistance
2. Talbot G.H., Bradley J., Edwards Jr. J., Gilbert D., Scheld M., and Bartlett J.G. Clin. Infect. Dis. 42 (2006) 657-668
3. van Heijenoort J. Nat. Prod. Rep. 8 (2001) 503-519
4. Bouhss A., Mengin-Lecreulx D., Le Beller D., and van Heijenoort J. Mol. Microbiol. 34 (1999) 576-585
5. Boyle D.S., and Donachie W.D. J. Bacteriol. 180 (1998) 6429-6432
6. van Heijenoort. J. Nat. Prod. Rep. 8 (2001) 503-519
7. Bouhss A., Trunkfield A.E., Bugg T.D.H., and Mengin-Lecreulx D. FEMS Microbiol. Rev. 32 (2008) 208-233
8. Bouhss A., Crouvoisier M., Blanot D., and Mengin-Lecreulx D. J. Biol. Chem. 279 (2004) 29974-29980
9. Known inhibitors of MraY, see for example:. Takatsuki A., Arima K., and Tamura G. J. Antibiot. 24 (1971) 215-223
10. Isono K., Uramoto M., Kusakabe H., Kimura K., Izaki K., Nelson C.C., and McCloskey J.A. J. Antibiot. 38 (1985) 1617-1621
11. Inukai M., Isono F., Takahashi S., Enokita R., Sakaida Y., and Haneishi T. J. Antibiot. 42 (1989) 662-666
12. Takeuchi, T.; Igarashi, M.; Naganawa, H.; Hamada, M. PCT Int. Appl. 2001, 73, WO 2001012643.
13. Igarashi M., Nakagawa N., Doi N., Hattori S., Naganawa H., and Hamada M. J. Antibiot. 56 (2003) 580-583
14. Dini C. Curr. Top. Med. Chem. 5 (2005) 1221-1236 and references cited therein
15. Gravier-Pelletier C., Charvet I., Le Merrer Y., and Depezay J.-C. J. Carbohydr. Res. 16 (1997) 129-141
16. Le Merrer Y., Gravier-Pelletier C., Guerrouache M., and Depezay J.-C. Tetrahedron Lett. 39 (1998) 385-388
17. Gravier-Pelletier C., Milla M., Le Merrer Y., and Depezay J.-C. Eur. J. Org. Chem. (2001) 3089-3096
18. Gravier-Pelletier C., Ginisty M., and Le Merrer Y. Tetrahedron: Asymmetry 15 (2004) 189-193
19. Ginisty M., Gravier-Pelletier C., and Le Merrer Y. Tetrahedron: Asymmetry 17 (2006) 142-150
20. Monasson O., Ginisty M., Bertho G., Gravier-Pelletier C., and Le Merrer Y. Tetrahedron Lett. 48 (2007) 8149-8152
21. Clouet A., Gravier-Pelletier C., Al-Dabbagh B., Bouhss A., and Le Merrer Y. Tetrahedron: Asymmetry 19 (2008) 397-400
22. For recent and selected synthetic approaches towards MraY inhibitors:. Knapp S., Moriello G.J., and Doss G.A. Org. Lett. 4 (2002) 603-606
23. Dini C., Didier-Laurent S., Drochon N., Feteanu S., Guillot J.C., Monti F., Uridat E., Zhang J., and Aszodi J. Bioorg. Med. Chem. Lett. 12 (2002) 1209-1213
24. Lin Y.I., Li Z., Francisco G.D., McDonald L.A., Davis R.A., Singh G., Yang Y., and Mansour T.S. Bioorg. Med. Chem. Lett. 12 (2002) 2341-2344
25. Howard N.I., and Bugg T.D.H. Bioorg. Med. Chem. 11 (2003) 3083-3099
26. Boojamra C.G., Lemoine R.C., Blais J., Vernier N.G., Stein K.A., Magon A., Chamberland S., Hecker S.J., and Lee V.J. Bioorg. Med. Chem. Lett. 13 (2003) 3305-3309
27. Yamashita A., Norton E., Petersen P., Rasmunssen B.A., Singh G., Yang Y., Mansour T., Tarek S., and Ho D.M. Bioorg. Med. Chem. Lett. 13 (2003) 3345-3350
28. Sarabia F., Martin-Ortiz L., and Lopez-Herrera F.J. Org. Lett. 5 (2003) 3927-3930
29. Ichikawa S., and Matsuda A. Nucleosides, Nucleotides, Nucleic Acids 24 (2005) 319-329
30. Hirano S., Ichikawa S., and Matsuda A. Angew. Chem., Int. Ed. 44 (2005) 1854-1856
31. Sarabia F., and Martin-Ortiz L. Tetrahedron 61 (2005) 11850-11865
32. Bourdreux Y., Drouillat B., and Greck C. Lett. Org. Chem. 3 (2006) 368-370
33. Hirano S., Ichikawa S., and Matsuda a. J. Org. Chem. 72 (2007) 9936-9946
34. Kurosu M., Mahapatra S., Narayanasamy P., and Crick D.C. Tetrahedron Lett. 48 (2007) 799-803
35. Drouillat B., Bourdreux Y., Perdon D., and Greck C. Tetrahedron: Asymmetry 18 (2007) 1955-1963
36. Hirano S., Ichikawa S., and Matsuda A. Tetrahedron 63 (2007) 2798-2804
37. Xu X.H., Trunkfield A.E., Bugg T.D.H., and Quing F.-L. Org. Biomol. Chem. 6 (2008) 157-161
38. Hirano S., Ichikawa S., and Matsuda A. Bioorg. Med. Chem. 16 (2008) 428-436
39. Hirano S., Ichikawa S., and Matsuda A. Bioorg. Med. Chem. 16 (2008) 5123-5133
40. For scaffolds with a seven-membered diazepane ring, see for example:. Giovannoni J., Subra G., Amblard M., and Martinez J. Tetrahedron Lett. 42 (2001) 5389-5392
41. Hirokawa Y., Horikawa T., Noguchi H., Yamamoto K., and Kato S. Org. Proc. Res. Dev. 6 (2002) 28-35
42. Lampariello L.R., Piras D., Rodriquez M., and Taddei M. J. Org. Chem. 68 (2003) 7893
43. Iden H.S., and Lubell W.D. Org. Lett. 8 (2006) 3425-3428
44. Liang G.-B., Qian X., Feng D., Biftu T., Eiermann G., He H., Leiting B., Lyons K., Petrov A., Sinha-Roy R., Zhang B., Wu J., Zhang X., Thornberry N.A., and Weber A.E. Bioorg. Med. Chem. Lett. 17 (2007) 1903-1907
45. Abushanab E., Vemishetti P., Leiby R.W., Singh H.K., Mikkilineni A.B., Wu D.C.J., Saibaba R., and Panzica R.P. J. Org. Chem. 53 (1988) 2598-2602
46. Gravier-Pelletier C., Dumas J., Le Merrer Y., and Depezay J.-C. J. Carbohydr. Res. 11 (1992) 969-998
47. Abushanab E., Bessodes M., and Antonakis K. Tetrahedron Lett. 25 (1994) 3841-3844
48. Lilly M.J., Miller N.A., Edwards A.J., Willis A.C., Turner P., Paddon-Row M.N., and Sherburn M.S. Chem. Eur. J. 11 (2005) 2525-2536
49. Wang Q., and Sasaki A. J. Org. Chem. 69 (2004) 4767-4773
50. Kolb H.C., and Sharpless K.B. Tetrahedron 48 (1992) 10515-10530
51. Castro B., Dormoy J.R., Dourtoglou B., Evin G., Selve C., and Ziegler J.C. Synthesis (1976) 751-752
52. Coste J., Castro B., and Le-Nguyen D. Tetrahedron Lett. 31 (1990) 205-208
53. Dourtoglou V., Ziegler J.C., and Gross B. Tetrahedron Lett. 19 (1978) 1269
54. Dourtoglou V., Gross B., Lambropoulou V., and Zioudrou C. Synthesis (1984) 572-574
55. Ginisty, M. Ph. D. thesis, Université René Descartes, 2005.
56. Mattson R.J., Pham K.M., Leuck D.J., and Cowen K.A. J. Org. Chem. 55 (1990) 2552-2554
57. Carre M.C., Houmounou J.P., and Caubere P. Tetrahedron Lett. 26 (1985) 3107-3110
58. Bennett F., Patel N.M., Girijavallabhan V.M., and Ganguly A.K. Synlett (1993) 3110-3118
59. Chini M., Crotti P., Favero L., Macchia F., and Pineschi M. Tetrahedron Lett. 35 (1994) 433-436
60. van de Weghe P., and Collin J. Tetrahedron Lett. 36 (1995) 1649-1652
61. Müller M., Müller R., Yu T.W., and Floss H.G. J. Org. Chem. 63 (1998) 9753-9755
62. Sabitha G., Babu R.S., Rajkumar M., and Yadav J.S. Org. Lett. 3 (2002) 343-345
63. Babič A., Sova M., Gobec S., and Pečar S. Tetrahedron Lett. 47 (2006) 1733-1735
64. Freidinger R.M., Hinkle J.S., Perlow D.S., and Arison B.H. J. Org. Chem. 48 (1983) 77-81
65. 3):. Rokach J., Adams J., and Perry R. Tetrahedron Lett. 24 (1983) 5185-5188
66. Le Merrer Y., Gravier C., Micas-Languin D., and Depezay J.C. Tetrahedron Lett. 27 (1986) 4161-4164
67. Le Merrer Y., Gravier-Pelletier C., Micas-Languin D., Mestre F., Duréault A., and Depezay J.C. J. Org. Chem. 54 (1989) 2409-2416
68. For HOBt use, see:. König W., and Geiger R. Ber. Dtsch. Chem. Ges. 103 (1970) 788-798
69. König W., and Geiger R. Ber. Dtsch. Chem. Ges. 103 (1970) 2024, 2034-2040
70. Albericio F., Bofill J.M., El-Faham A., and Kates S.A. J. Org. Chem. 63 (1998) 9678-9683
71. Nefzi A., Ostresh J.M., and Houghten R.A. Tetrahedron Lett. 38 (1997) 4943-4946
72. Xu Y., Chen L., Ma Y., Li J., and Cao X. Synlett (2007) 1901-1904
73. Le Corre L., Gravier-Pelletier C., and Le Merrer Y. Eur. J. Org. Chem. (2007) 5386-5394
74. For a review of peptidomimetics, see: Mini-Rev. Med. Chem. 2002, 2, 433-517.
75. This compound was already prepared under Mitsunobu conditions, see Ref. 8c.